Robert A. Ramirez

4.6k total citations
63 papers, 813 citations indexed

About

Robert A. Ramirez is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Robert A. Ramirez has authored 63 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 40 papers in Epidemiology and 26 papers in Neurology. Recurrent topics in Robert A. Ramirez's work include Neuroendocrine Tumor Research Advances (40 papers), Lung Cancer Research Studies (37 papers) and Neuroblastoma Research and Treatments (26 papers). Robert A. Ramirez is often cited by papers focused on Neuroendocrine Tumor Research Advances (40 papers), Lung Cancer Research Studies (37 papers) and Neuroblastoma Research and Treatments (26 papers). Robert A. Ramirez collaborates with scholars based in United States, Australia and China. Robert A. Ramirez's co-authors include Aman Chauhan, Eugene A. Woltering, J. Philip Boudreaux, Yi‐Zarn Wang, Ramcharan Thiagarajan, Raymond U. Osarogiagbon, Katharine Thomas, Xinhua Yu, Allen D. Berry and Laura E. Miller and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Robert A. Ramirez

56 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Ramirez United States	16	474	412	291	220	77	63	813
Jonas Schumacher Germany	4	228 0.5×	301 0.7×	169 0.6×	60 0.3×	194 2.5×	7	590
Ling Jia China	15	190 0.4×	142 0.3×	36 0.1×	104 0.5×	32 0.4×	34	484
Clayton D. Knox United States	13	250 0.5×	167 0.4×	122 0.4×	57 0.3×	10 0.1×	19	582
Johannes Schmitt Germany	14	149 0.3×	263 0.6×	75 0.3×	18 0.1×	33 0.4×	28	542
Feng Xue China	13	111 0.2×	114 0.3×	40 0.1×	87 0.4×	65 0.8×	49	506
Jay A. Cherner United States	11	208 0.4×	420 1.0×	146 0.5×	78 0.4×	14 0.2×	17	985
Desen Wan China	15	430 0.9×	64 0.2×	26 0.1×	178 0.8×	41 0.5×	65	762
Regina Lamberts Germany	9	78 0.2×	153 0.4×	67 0.2×	95 0.4×	41 0.5×	13	550
J.B. Foidart Belgium	13	93 0.2×	99 0.2×	78 0.3×	62 0.3×	49 0.6×	24	534

Countries citing papers authored by Robert A. Ramirez

Since Specialization

Citations

This map shows the geographic impact of Robert A. Ramirez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Ramirez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Ramirez more than expected).

Fields of papers citing papers by Robert A. Ramirez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Ramirez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Ramirez. The network helps show where Robert A. Ramirez may publish in the future.

Co-authorship network of co-authors of Robert A. Ramirez

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Ramirez. A scholar is included among the top collaborators of Robert A. Ramirez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Ramirez. Robert A. Ramirez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holowatyj, Andreana N., Deepa Magge, Deborah Shelton, et al.. (2025). The presenting symptoms of patients with appendiceal malignant tumors.. Journal of Clinical Oncology. 43(4_suppl). 824–824. 1 indexed citations

Zhao, Jiaming, Guoxia Wang, Qihao Wang, et al.. (2024). A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring EML4-ALK rearrangement. Translational Lung Cancer Research. 13(5). 1150–1162. 1 indexed citations

Rutherford, Megan J., et al.. (2024). Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumors. Current Problems in Cancer. 49. 101061–101061. 3 indexed citations

Das, Satya, Sharon Phillips, Rajiv Agarwal, et al.. (2023). Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours – A systematic review and meta-analysis. European Journal of Cancer. 182. 43–52. 2 indexed citations

Chen, Yueyun, Chunhua Liu, Francesco Panzuto, et al.. (2023). Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma. Journal of Gastrointestinal Oncology. 14(6). 2309–2323. 5 indexed citations

Dai, Jie, Xinsheng Zhu, Dianke Li, et al.. (2022). Sleeve resection after neoadjuvant chemoimmunotherapy in the treatment of locally advanced non-small cell lung cancer. Translational Lung Cancer Research. 11(2). 188–200. 13 indexed citations

Ramirez, Robert A., Katharine Thomas, Aasems Jacob, et al.. (2021). Adjuvant therapy for lung neuroendocrine neoplasms. World Journal of Clinical Oncology. 12(8). 664–674. 8 indexed citations

Woltering, Eugene A., et al.. (2019). Role of Plasma Pancreastatin in Predicting Prognosis Following R0/R1 Surgical Cytoreduction in Small Bowel Neuroendocrine Tumors. Pancreas. 48(3). 456–456. 1 indexed citations

Naraev, Boris G., Robert A. Ramirez, A. Tuba Kendi, & Þorvarður R. Hálfdánarson. (2019). Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids. Clinical Lung Cancer. 20(3). e376–e392. 29 indexed citations

10.

Saif, Muhammad Wasif, Rohan Parikh, James A. Kaye, et al.. (2019). Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors. Journal of Gastrointestinal Oncology. 10(4). 674–687. 8 indexed citations

11.

Bergsland, Emily K., Thomas A. Hope, Pamela L. Kunz, et al.. (2018). P1.12-06 Pulmonary Neuroendocrine (Carcinoid) Tumors: CommNETs/NANETS Endorsement and Update of the ENETs Best Practice Consensus. Journal of Thoracic Oncology. 13(10). S575–S575. 1 indexed citations

12.

Woltering, Eugene A., et al.. (2017). Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution. Journal of the American College of Surgeons. 224(4). 434–447. 58 indexed citations

13.

Ruiz, Marco & Robert A. Ramirez. (2015). Lung cancer in HIV-infected patients and the role of targeted therapy. The Journal of Community and Supportive Oncology. 13(8). 282–287. 3 indexed citations

14.

Woltering, Eugene A., et al.. (2015). Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum. Journal of the American College of Surgeons. 222(4). 534–542. 11 indexed citations

15.

Chauhan, Aman & Robert A. Ramirez. (2015). Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series. Lung. 193(5). 653–657. 23 indexed citations

16.

Osarogiagbon, Raymond U., Robert A. Ramirez, Laura E. Miller, et al.. (2014). Size and histologic characteristics of lymph node material retrieved from tissue discarded after routine pathologic examination of lung cancer resection specimens. Annals of Diagnostic Pathology. 18(3). 136–139. 8 indexed citations

17.

Osarogiagbon, Raymond U., Laura E. Miller, Robert A. Ramirez, et al.. (2012). Use of a Surgical Specimen-Collection Kit to Improve Mediastinal Lymph-Node Examination of Resectable Lung Cancer. Journal of Thoracic Oncology. 7(8). 1276–1282. 24 indexed citations

18.

Ramirez, Robert A., et al.. (2012). Alterations in mast cell frequency and relationship to angiogenesis in the rat mammary gland during windows of physiologic tissue remodeling. Developmental Dynamics. 241(5). 890–900. 22 indexed citations

19.

Quinones, Marlon P., Yogeshwar Kalkonde, Carlos A. Estrada, et al.. (2007). Role of astrocytes and chemokine systems in acute TNFα induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-κB and Akt. Molecular and Cellular Neuroscience. 37(1). 96–109. 47 indexed citations

20.

Masso‐Welch, Patricia A., Danilo Zangani, Clement Ip, et al.. (2002). Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.. PubMed. 62(15). 4383–9. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact